Core Laboratories trades near 5-year lows but suffers from limited investor interest and unclear financial segment breakdowns. Read why I rate CLB stock a hold.

CLB's second-quarter earnings beat estimates. However, it declined year over year due to the underperformance of the ...

Core Laboratories Inc. CLB reported third-quarter 2024 adjusted earnings of 25 cents per share, which beat the Zacks Consensus Estimate of 21 cents. The bottom line also increased from the year ...

Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.